Lexpos News

/Lexpos News

MHRA Drug Safety Update: December 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 5 December 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in November 2024 To see th...

By |December 12th, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: December 2024

Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues will be made indefinite

Today the Government announced that regulations restricting the prescribing and supply of puberty-suppressing hormones – which were due to expire at the end of December –will be made indefinite. The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 will come into force on 1 January 2025 as the current emergency order expires and [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues will be made indefinite appeared first on Community Pharmacy England.

By |December 11th, 2024|Lexpos News|Comments Off on Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues will be made indefinite

Additional non-CCA multiples appointed to Community Pharmacy England Committee

The Managing Director of Jardines (UK) Ltd and Superintendent Pharmacist of Pearl Chemist Group have been selected as non-CCA multiple observers to the Community Pharmacy England Committee. The establishment of two contributing observer places is an interim measure to ensure pharmacy owners with 10 or more pharmacies are well represented, while the Committee considers more [...]

The post Additional non-CCA multiples appointed to Community Pharmacy England Committee appeared first on Community Pharmacy England.

By |December 11th, 2024|Lexpos News|Comments Off on Additional non-CCA multiples appointed to Community Pharmacy England Committee

SSP077 for Cefalexin 125mg/5ml oral suspension sugar free further extended

Update 02/05/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Cefalexin 125mg/5ml oral suspension sugar free (SSP077) which was due to expire 02 May 2025 but has been further extended to Friday 1 August 2025. Community Pharmacy England’s in-house Drug Tariff and funding [...]

The post SSP077 for Cefalexin 125mg/5ml oral suspension sugar free further extended appeared first on Community Pharmacy England.

By |December 10th, 2024|Lexpos News|Comments Off on SSP077 for Cefalexin 125mg/5ml oral suspension sugar free further extended

NHS Smartcard action required: checking contact info, self unlock and expiry

NHS England and Community Pharmacy England recommend that pharmacy team members with NHS Smartcards consider taking the following actions to support ongoing use of their smartcards. If your smartcard or role on your smartcard was set up a long time ago, there may be an action for you to update it to keep it working. [...]

The post NHS Smartcard action required: checking contact info, self unlock and expiry appeared first on Community Pharmacy England.

By |December 9th, 2024|Lexpos News|Comments Off on NHS Smartcard action required: checking contact info, self unlock and expiry